DAC Patient Recruitment Services, a Dallas-based company focused on patient recruitment and retention for clinical trials, has renewed its commitment to the Society for Clinical Research Sites (SCRS), a global trade organization, as a Global Impact Partner (GIP) for a second term.
In this role, DAC will continue to serve on the SCRS Global Impact Board at an executive level and work closely with the SCRS Leadership Council on its strategic initiatives to support the interests of the clinical research site community internationally.
“We at DAC are fortunate to have the privilege of working with sites and sponsors on a daily basis,” said Steve Swanson, DAC chief executive officer and GIP board representative. “SCRS is a key component in allowing us more insight into the site perspective. Our support and participation as a Global Impact Partner further expand our commitment to the clinical trial industry and allows us to play a bigger role in assuring sites have an increasing voice in issues that impact our industry, as well as providing access to best-practices resources.”
The GIP board is made up of 12 industry organizations that collaborate with SCRS during two-year terms to promote the interests of clinical trial sites on such matters as operational management, contracts and subject recruitment and retention. Each organization selects one executive-level team member to serve on the board.